Skip to main content
SpringerLink
Log in

“Is there any association between insulin resistance and thyroid cancer? : a case control study”

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Insulin stimulates proliferation of thyroid cells in culture. The presence of insulin resistance (IR) is associated with larger thyroid gland volume and an increased prevalence of thyroid nodules. The aim of this study was to investigate the presence of any possible association between IR and thyroid cancer. Forty-one patients with diffuse thyroid cancer (Group 1) were matched for age and gender with 41 patients with nodular goiter (Group 2). Both groups were compared in terms of frequency of IR, as estimated by the homeostasis model assessment, as well as other parameters of the metabolic syndrome (MetS). Fourteen patients (34.1 %) in each group had MetS. Twelve patients (29.3 %) in group 1 had IR compared to 10 (24.4 %) in group 2. Mean HOMA-IR scores in group 1 and 2 were 2.5 ± 2.2 and 1.8 ± 1.1, respectively. Thirty-two patients (78 %) in group 1 had a body mass index (BMI) of more than 25 compared to 33 patients (80.5 %) in group 2. The difference between groups with regard to HOMA-IR, the frequency of IR, BMI, and any of the parameters of MetS was statistically insignificant (p > 0.05). A subgroup analysis based on tumor size did not reveal a significant difference between patients with microcarcinoma (≤10 mm) and macrocarcinoma (>10 mm) in terms of any of the study parameters (p > 0.05). Neither MetS nor IR was a significant risk factor for thyroid cancer following logistic regression analysis (p > 0.05). IR is not more prevalent in patients with thyroid cancer. Some other pathologic mechanisms may be more prominent during thyroid carcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. G.M. Reaven, Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37, 1595–1607 (1988)

    Article  CAS  PubMed  Google Scholar 

  2. G. Hu, Q. Qiao, J. Tuomilehto, The metabolic syndrome and cardiovascular risk. Curr. Diabetes Rev. 1, 137–143 (2005)

    Article  PubMed  Google Scholar 

  3. R.L. Ahmed, K.H. Schmitz, K.E. Anderson, W.D. Rosamond, A.R. Folsom, The metabolic syndrome and risk of incident colorectal cancer. Cancer 107, 28–36 (2006)

    Article  PubMed  Google Scholar 

  4. L. Lund Haheim, T.F. Wisloff, I. Holme, P. Nafstad, Metabolic syndrome predicts prostate cancer in a cohort of middleaged Norwegian men followed for 27 years. Am. J. Epidemiol. 164, 769–774 (2006)

    Article  CAS  PubMed  Google Scholar 

  5. W.G. Nelson, A.M. De Marzo, T.L. DeWeese, W.B. Isaacs, The role of infl ammation in the pathogenesis of prostate cancer. J. Urol. 172, 6–11 (2004)

    Article  Google Scholar 

  6. R. Kaaks, A. Lukanova, B. Sommersberg, Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review. Prostate Cancer Prostatic Dis. 3, 157–172 (2000)

    Article  CAS  PubMed  Google Scholar 

  7. E.A. Platz, A.M. De Marzo, Epidemiology of infl ammation and prostate cancer. J. Urol. 171, 36–40 (2004)

    Article  Google Scholar 

  8. B.A. Kilfoy, S.S. Devesa, M.H. Ward, Y. Zhang, P.S. Rosenberg, T.R. Holford, W.F. Anderson, Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol. Biomarkers Prev. 18, 1092–1100 (2009)

    Article  PubMed Central  PubMed  Google Scholar 

  9. B.A. Kilfoy, T. Zheng, T.R. Holford, X. Han, M.H. Ward, A. Sjodin, Y. Zhang, Bai, C. Zhu, G.L. Guo, N. Rothman, Y. Zhang, International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20, 525–531 (2009)

    Article  PubMed Central  PubMed  Google Scholar 

  10. L. Pagano, M. Caputo, M.T. Samà, V. Garbaccio, M. Zavattaro, M.G. Mauri, F. Prodam, P. Marzullo, R. Boldorini, G. Valente, G. Aimaretti, Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997–2010): data from the University Hospital “Maggiore della Carità” in Novara. Endocrine 42, 382–390 (2012)

    Article  CAS  PubMed  Google Scholar 

  11. F. Pacini, Changing natural history of differentiated thyroid cancer. Endocrine 42, 229–230 (2012)

    Article  CAS  PubMed  Google Scholar 

  12. J. Rezzonico, M. Rezzonico, E. Pusiol, F. Pitoia, H. Niepomniszcze, Introducing the thyroid gland as another victim of the insülin resistance syndrome. Thyroid 18, 461–464 (2008)

    Article  CAS  PubMed  Google Scholar 

  13. S. Ayturk, A. Gursoy, A. Kut, C. Anil, A. Nar, N.B. Tutuncu, Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur. J. Endocrinol. 161, 599–605 (2009)

    Article  CAS  PubMed  Google Scholar 

  14. J.N. Rezzónico, M. Rezzónico, E. Pusiol, F. Pitoia, H. Niepomniszcze, Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab. Syndr. Relat. Disord. 7, 375–380 (2009)

    Article  PubMed  Google Scholar 

  15. Arslan M., Atmaca A., Ayvaz G., Başkal N., Beyhan Z., Bolu E., Can S., Corakcı A. et al.: Metabolik Sendrom Kılavuzu. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Derneği, Metabolik Sendrom Çalışma Grubu. Metrix matbaacılık, İstanbul (2007)

  16. J. Brunn, U. Block, G. Ruf, I. Bos, W.P. Kunze, P.C. Scriba, Volumetric analysis of thyroid lobes by real-time ultrasound. Dtsch. Med. Wochenschr. 106, 1338–1340 (1981)

    Article  CAS  PubMed  Google Scholar 

  17. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985)

    Article  CAS  PubMed  Google Scholar 

  18. D.R. Clemmons, Structural and functional analysis of insulin-like growth factors. Br. Med. Bull. 45, 465–480 (1989)

    CAS  PubMed  Google Scholar 

  19. R. Paramesweran, S. Brooks, G.P. Sadler, Molecular pathogenesis of follicular cell derived thyroid cancers. Int. J. Surg. 8, 186–193 (2010)

    Article  Google Scholar 

  20. T. Stocks, K. Rapp, T. Bjørge, J. Manjer, H. Ulmer, R. Selmer, A. Lukanova, D. Johansen, H. Concin, S. Tretli, G. Hallmans, H. Jonsson, P. Stattin, Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer Project (me-can): analysis of six prospective cohorts. PLoS Med. 6, e1000201 (2009)

    Article  PubMed Central  PubMed  Google Scholar 

  21. B. Aschebrook-Kilfoy, M.M. Sabra, A. Brenner, S.C. Moore, E. Ron, A. Schatzkin, A. Hollenbeck, M.H. Ward, Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study. Thyroid 21, 957–963 (2011)

    Article  PubMed  Google Scholar 

  22. C.H. Tseng, Thyroid cancer risk ıs not ıncreased in diabetic patients. PLoS One 7, e53096 (2012)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. D.M. Freedman, A.C. Looker, C.C. Abnet, M.S. Linet, B.I. Graubard, Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988–2006). Cancer Res. 70, 8587–8597 (2010)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. D.M. Freedman, A.C. Looker, S.C. Chang, B.I. Graubard, Prospective study of serum vitamin D and cancer mortalityin the United States. Natl. Cancer Inst. 7, 1594–1602 (2007)

    Article  Google Scholar 

  25. E. Giovannucci, Epidemiological evidence for vitamin D and colorectal cancer. J. Bone Miner. Res. 22, V81–V85 (2007)

    Article  CAS  PubMed  Google Scholar 

  26. E. Giovannucci, Vitamin D status and cancer incidence and mortality. Adv. Exp. Med. Biol. 624, 31–42 (2008)

    Article  CAS  PubMed  Google Scholar 

  27. D. Macejova, S. Ondkova, J. Brtko, Vitamin D(3) affects expression of thyroid hormone receptor alpha and deiodinase activity in liver of MNU-treated Sprague-Dawley rats. Gen. Physiol. Biophys. 28, 363–370 (2009)

    Article  CAS  PubMed  Google Scholar 

  28. J. Köhrle, Thyroid hormone transporters in health and disease: advances in thyroid hormone deiodination. Best Pract. Res. Clin. Endocrinol. Metab. 21, 173–191 (2007)

    Article  PubMed  Google Scholar 

  29. J. Köhrle, Local activation and inactivation of thyroid hormones: the deiodinase family. Mol. Cell. Endocrinol. 151, 103–119 (1999)

    Article  PubMed  Google Scholar 

  30. E.A. Platz, A.M. De Marzo, Epidemiology of inflammation and prostate cancer. J. Urol. 171, 36–40 (2004)

    Article  Google Scholar 

  31. G. Vitale, M.P. Brugts, G. Ogliari, D. Castaldi, L.M. Fatti, A.J. Varewijck, S.W. Lamberts, D. Monti, L. Bucci, E. Cevenini, F. Cavagnini, C. Franceschi, L.J. Hofland, D. Mari, J. Janssen, Low circulating IGF-I bioactivity is associated with human longevity: Findings in centenarians’ offspring. Aging (Albany NY) 4, 580–589 (2012)

    CAS  Google Scholar 

  32. P. Vigneri, F. Frasca, L. Sciacca, G. Pandini, R. Vigneri, Diabetes and cancer. Endocr. Relat. Cancer 16, 1103–1123 (2009)

    Article  CAS  PubMed  Google Scholar 

  33. Y.J. Liu, W. Qiang, J. Shi, S.Q. Lv, M.J. Ji, B.Y. Shi, Expression and significance of IGF-1 and IGF-1R in thyroid nodules. Endocrine (2013). doi:10.1007/s12020-012-9864-z

    Google Scholar 

Download references

Conflict of interest

The authors declare that there is no conflict of interest and the study complies with the current laws of their country.

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, Yildirim Beyazit University Medical School Ataturk Teaching and Research Hospital, Bilkent, Ankara, Turkey

    Fevzi Balkan, Eda Demir Onal, Alper Usluogullari, Dilek Tuzun, Didem Ozdemir, Serap Soytac Inancli, Reyhan Ersoy & Bekir Cakir

Authors
  1. Fevzi Balkan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eda Demir Onal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alper Usluogullari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dilek Tuzun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Didem Ozdemir
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Serap Soytac Inancli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Reyhan Ersoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bekir Cakir
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fevzi Balkan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Balkan, F., Onal, E.D., Usluogullari, A. et al. “Is there any association between insulin resistance and thyroid cancer? : a case control study”. Endocrine 45, 55–60 (2014). https://doi.org/10.1007/s12020-013-9942-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-013-9942-x

Keywords

Search

Navigation